Is CIBER, Inc. (CBR) a Good Stock to Buy?

Seeing as CIBER, Inc. (NYSE:CBR) has faced declining sentiment from the aggregate hedge fund industry, it’s safe to say that there lies a certain “tier” of money managers that slashed their entire stakes last quarter. At the top of the heap, Benjamin A. Smith’s Laurion Capital Management dumped the biggest position of the “upper crust” of funds tracked by Insider Monkey, valued at an estimated $0.4 million in stock. Peter Rathjens, Bruce Clarke and John Campbell’s fund, Arrowstreet Capital, also dumped its stock, about $0.1 million worth.

Let’s check out hedge fund activity in other stocks – not necessarily in the same industry as CIBER, Inc. (NYSE:CBR) but similarly valued. These stocks are ADMA Biologics Inc (NASDAQ:ADMA), Harvard Bioscience, Inc. (NASDAQ:HBIO), Xcel Brands Inc (NASDAQ:XELB), and FBR & Co (NASDAQ:FBRC). This group of stocks’ market valuations resemble CBR’s market valuation.

As you can see these stocks had an average of 5 hedge funds with bullish positions and the average amount invested in these stocks was $18 million. That figure was $6 million in CBR’s case. ADMA Biologics Inc (NASDAQ:ADMA) is the most popular stock in this table. On the other hand Xcel Brands Inc (NASDAQ:XELB) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks CIBER, Inc. (NYSE:CBR) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None